Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep470 | Pituitary and Neuroendocrinology | ECE2021

Nonfunctioning pituitary adenomas: What can we do? What we did

Mallea-Gil Susana , Cuccia Mariela , Tubert Gloria , Diez Sabrina , Ballarino Carolina

Nonfunctioning pituitary adenomas (NFAs) have no symptoms of hormonal overproduction and can be asymptomatic or have severe symptoms due to mass effects. The aim of our study was to assess clinical features and therapeutic outcomes in patients with clinically NFAs. We retrospectively collected data of 175 patients from 3 hospitals of Buenos Aires. Mean age: 51 years (r:13–90), 52% women, mean follow-up: 7.37 years. At diagnosis, clinical presentation was: visual field def...

ea0070aep672 | Pituitary and Neuroendocrinology | ECE2020

Giant prolactinomas: Is it possible to stop treatment?

Mallea-Gil Susana , Diez Sabrina , Tubert Gloria , Cuccia Mariela , Rodriguez Noelia , Stalldecker Graciela , de los Angeles Sosa Maria , Peressotti Bruno , Palazzo Adriana , Ballarino Carolina

Giant prolactinomas are tumors with a large size >4 cm and/or prolactin levels higher than 3000 ng/ml and/or highly invasive growth. Today dopamine agonists (DA), mainly cabergoline (CAB), are the first-line choice in the treatment of these tumorsTo assess the efficacy, safety and long-term follow-up of patients with giant prolactinomas treated with DA. We retrospectively reviewed the clinical records of 33 patients with giant prolactinomas. Mea...